June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

MONTREAL, CANADA--Aurora Interactive, a world leader in digital pathology communications, announced Thursday the company has signed a partnership contract with Galderma, a global leading pharmaceutical company specializing in the...

The novel staining approach combines the multiplexing capabilities of fluorescence with the tissue context of brightfield whole slide scanning FLAGSTAFF, Ariz. — March 17, 2011 — Flagship Biosciences announced today a novel whole slide...

CHICAGO – March 14, 2011 – President Bill Clinton, the Founder of the William J. Clinton Foundation and the 42nd President of the United States and a champion for global health, will be the keynote speaker at the 2011 American Society for...

HAMAMATSU, Japan, March 15, 2011 /PRNewswire/ -- Hamamatsu Photonics K.K. (HPK) is pleased to announce that is has been awarded Reissue Patent No. 42,220 ("RE42,220"), confirming the patentability of its original...

Transforming Pathology AccelPath has developed a proprietary workflow system to quickly provide high quality, sub-specialized pathology interpretations to referring physicians and laboratories. Simple steps to state-of-the-art pathology...

I am becoming increasingly suspicious of articles and media reports that claim something to the effect that ""X" is no longer most common cause of "Y"; Genetic cause found for disease". Such as the case with this...

OR

platinum partners

gold partners

Silver Partners

Media Partners